bluebird bio, Inc.
BLUE · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $48 | $535 | $666 | $1,251 |
| - Cash | $79 | $62 | $71 | $144 |
| + Debt | $188 | $358 | $365 | $390 |
| Enterprise Value | $157 | $831 | $960 | $1,497 |
| Revenue | $39 | $39 | $11 | $16 |
| % Growth | 0.5% | 263% | -34.1% | – |
| Gross Profit | $26 | $16 | -$1 | -$13 |
| % Margin | 68.4% | 40.8% | -11% | -79.8% |
| EBITDA | -$8 | -$9 | -$40 | -$59 |
| % Margin | -19.8% | -23.4% | -374.5% | -368.9% |
| Net Income | -$29 | -$29 | -$61 | -$81 |
| % Margin | -75.1% | -74.5% | -573% | -505.5% |
| EPS Diluted | -2.98 | -0.45 | -0.95 | -1.27 |
| % Growth | -562.2% | 52.6% | 25.2% | – |
| Operating Cash Flow | -$43 | -$50 | -$69 | -$66 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$44 | -$51 | -$69 | -$66 |